Product Information

METOPROLOL SUCC ER 50 MG TAB is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0555 per EA under NDC 82009011405. Its NADAC has been published 168 times since Sep 6, 2023.

FDA first approved this application on Aug 1, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METOPROLOL SUCC ER 50 MG TAB

Metoprolol succinate
$0.0555per EA

Strength

50 mg/1

NDC

82009011405

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METOPROLOL SUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090617

FDA Approved

8/1/2012

TE Code

AB

On Market Since

7/20/2023

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for METOPROLOL SUCC ER 50 MG TAB has been published 168 times since Sep 6, 2023, and over the history we have for it it has declined 28.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0555 per EA
All-time high$0.0838 (Apr 10, 2024)
All-time low$0.0494 (Oct 21, 2026)
52-week high$0.0655
52-week low$0.0494
Median price$0.0637
Average price$0.0635
Largest weekly change-32.0% (Apr 17, 2024)
Weeks tracked168
Tracking sinceSep 6, 2023

Price History

1W

+12.3%

1M

+7.7%

3M

-2.7%

6M

+2.9%

1Y

-13.3%

3Y

-28.3%

5Y

N/A

All

-28.5%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METOPROLOL SUCC ER 50 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 50 MG TAB, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0555 per EA (NDC 82009011405), effective Nov 18, 2026.

How has the price of METOPROLOL SUCC ER 50 MG TAB changed over time?

Over the history we have for it, the NADAC for METOPROLOL SUCC ER 50 MG TAB has declined 28.5%. It has been tracked across 168 weekly CMS publications since Sep 6, 2023.

What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 50 MG TAB?

Since Sep 6, 2023, the NADAC for METOPROLOL SUCC ER 50 MG TAB has ranged from a low of $0.0494 (Oct 21, 2026) to a high of $0.0838 (Apr 10, 2024), with a median of $0.0637 per EA.

Are there cheaper alternatives to METOPROLOL SUCC ER 50 MG TAB?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL SUCC ER 50 MG TAB, is $0.0539 per EA — about 3% below METOPROLOL SUCC ER 50 MG TAB.

Who manufactures METOPROLOL SUCC ER 50 MG TAB?

METOPROLOL SUCC ER 50 MG TAB (NDC 82009011405) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.